United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read General business news LondonMetric to acquire Highcroft Investments in £43.8m all-share deal LondonMetric Property plans to acquire Highcroft Investments in a £43.8 million all-share deal, offering shareholders a 40.4% premium. Find out what it means for investors! byPallavi MadhirajuMarch 27, 2025